Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03602833
Recruitment Status : Recruiting
First Posted : July 27, 2018
Last Update Posted : June 30, 2021
Sponsor:
Collaborator:
Merck KGaA, Darmstadt, Germany
Information provided by (Responsible Party):
Royal Marsden NHS Foundation Trust

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 31, 2022
Estimated Study Completion Date : January 31, 2023